Literature DB >> 24943254

Influence of smoking history on imaging characteristics among patients with human papillomavirus-positive oropharyngeal cancer: a blinded matched-pair analysis.

Sarah C Cantrell1, Holly H Reid, Guojun Li, Qingyi Wei, Erich M Sturgis, Lawrence E Ginsberg.   

Abstract

BACKGROUND AND
PURPOSE: Human papillomavirus (HPV)-positive oropharyngeal cancers represent a distinct clinical entity with more favorable prognosis than do HPV-negative oropharyngeal cancers. However, among patients with HPV-positive oropharyngeal carcinomas, those with a significant smoking history have a much worse prognosis. Recently, imaging characteristics of oropharyngeal cancers were identified as markers of poor prognosis. The purpose of this study was to determine whether nodal imaging characteristics differ between smokers and never/light smokers with HPV-positive oropharyngeal cancer.
MATERIALS AND METHODS: A review of 130 pretreatment computed tomographic examinations of HPV-positive oropharyngeal cancers in smokers (>10 pack-years) and never/light smokers (10 pack-years) matched for T stage and tumor subsite was performed, with the reviewing radiologist blinded to the HPV status, smoking history, and clinical stage. Additionally 24 pretreatment computed tomographic examinations of patients with HPV-negative oropharyngeal cancers were also reviewed in a blinded fashion. Imaging characteristics of metastatic nodal disease were compared using the testing (Fisher exact testing where appropriate) and McNemar testing for the matched-pair analysis.
RESULTS: As expected, those with HPV-positive oropharyngeal cancer were more likely to be younger, male, non-Hispanic white, never/former smokers, and never drinkers than were those with HPV-negative oropharyngeal cancer. Furthermore, the HPV-positive oropharyngeal cancers were more likely to be in the tonsil, smaller T category, higher N category, poorly differentiated, than were the HPV-negative oropharyngeal cancers. However, among the HPV-positive oropharyngeal cancers, we could identify no obvious difference in the pretreatment imaging characteristics of paired smokers and never/light smokers.
CONCLUSIONS: Among the patients with HPV-positive oropharyngeal cancer, no imaging characteristics were identified to correlate with the critical prognostic feature smoking status. Cystic and necrotic nodal metastases, as described previously, were more common among the patients with HPV-positive than those with HPV-negative oropharyngeal cancers. Although cystic nodal metastases were more common among the never/light smokers with HPV-positive oropharyngeal cancer than among smokers with HPV-positive oropharyngeal cancer, however, because these results did not reach statistical significance, we concluded that the imaging results cannot serve as a surrogate for an HPV-driven phenotype.

Entities:  

Mesh:

Year:  2014        PMID: 24943254      PMCID: PMC4318505          DOI: 10.1097/RCT.0000000000000100

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  28 in total

1.  Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years.

Authors:  Caroline H Shiboski; Brian L Schmidt; Richard C K Jordan
Journal:  Cancer       Date:  2005-05-01       Impact factor: 6.860

2.  Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue.

Authors:  J N Myers; J S Greenberg; V Mo; D Roberts
Journal:  Cancer       Date:  2001-12-15       Impact factor: 6.860

3.  Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database.

Authors:  André Lopes Carvalho; Inês Nobuko Nishimoto; Joseph A Califano; Luiz Paulo Kowalski
Journal:  Int J Cancer       Date:  2005-05-01       Impact factor: 7.396

4.  Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.

Authors:  Paul M Weinberger; Ziwei Yu; Bruce G Haffty; Diane Kowalski; Malini Harigopal; Janet Brandsma; Clarence Sasaki; John Joe; Robert L Camp; David L Rimm; Amanda Psyrri
Journal:  J Clin Oncol       Date:  2006-01-09       Impact factor: 44.544

5.  Case-control study of human papillomavirus and oropharyngeal cancer.

Authors:  Gypsyamber D'Souza; Aimee R Kreimer; Raphael Viscidi; Michael Pawlita; Carole Fakhry; Wayne M Koch; William H Westra; Maura L Gillison
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

6.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

7.  Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; William F Anderson; Maura L Gillison
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

Review 8.  Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?

Authors:  Erich M Sturgis; Paul M Cinciripini
Journal:  Cancer       Date:  2007-10-01       Impact factor: 6.860

9.  Primary head and neck cancer. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement.

Authors:  K D Olsen; M Caruso; R L Foote; R J Stanley; J E Lewis; S J Buskirk; D A Frassica; L W DeSanto; W M O'Fallon; V R Hoverman
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1994-12

10.  Differences in imaging characteristics of HPV-positive and HPV-Negative oropharyngeal cancers: a blinded matched-pair analysis.

Authors:  S C Cantrell; B W Peck; G Li; Q Wei; E M Sturgis; L E Ginsberg
Journal:  AJNR Am J Neuroradiol       Date:  2013-05-09       Impact factor: 3.825

View more
  1 in total

1.  Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.

Authors:  Linda X Yin; Gypsyamber D'Souza; William H Westra; Steven J Wang; Annemieke van Zante; Yuehan Zhang; Eleni M Rettig; William R Ryan; Patrick K Ha; Alicia Wentz; Wayne Koch; David W Eisele; Carole Fakhry
Journal:  Laryngoscope       Date:  2018-03-14       Impact factor: 3.325

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.